Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of COULTREON BIOPHARMA is 1.1% (low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
3 mandates
3
active directors
Lawrence BlattDirectorVuldex Consulting BVDirectorPierre Raboisson BVManaging director
All directors & mandates Publicationslatest 05-05-2026
17
publications in the State GazetteArticles of association amended — translation of the articles, coordination of the articles and amendment of specific…All publications & acts Network & structure
6
connected companiesSee network & structure
Connections
6 connected companiesTrust signals
3 signalsYoung company
Founded in 2025 — under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.1%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109
Primary activity highlighted.
Names & trade names
| Legal nameNL | COULTREON BIOPHARMA |
| Legal nameNL | ONCO3R Therapeutics |
| AbbreviationNL | COULTREON |
Registered office
Gaston Geenslaan 3
3001 Leuven, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.